• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Nidek sister companies consolidate U.S. business activities


Nidek Co. Ltd.'s two wholly owned subsidiaries-Nidek Technologies America (NTA), Greensboro, NC, and Nidek Inc., Fremont, CA-will merge and consolidate business activities in the U.S. market, effective April 1, 2006.

The Gamagori, Japan-based company said it expects this action to harmonize and harness commercial synergies further and to solidify Nidek's U.S. business. In addition, the transaction is a strategic move to further product marketing/distribution goals and objectives in the United States, according to Nidek.

NTA's focus is on commercializing advanced ophthalmic diagnostic instrumentation for corneal and retinal applications, while the focus of Nidek Inc. is the U.S. sales and marketing organization.

"Bringing the two groups together will allow Nidek to offer one source for its advanced diagnostics and surgical ophthalmic instrumentation to the vision-care professional in the United States," said Hideo Ozawa, president and founder of Nidek Co. Ltd. "Additionally, through this consolidation, we aim to streamline business operations-sales, marketing, accounting, and customer and product service-enabling Nidek to focus and achieve its short- and long-term goals and objectives."

Related Videos
© 2024 MJH Life Sciences

All rights reserved.